SynthesisCancer medicine2026

Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Anti-Angiogenic Tyrosine Kinase Inhibitors for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.

Rongyi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.